| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |